Cagent Vascular Announces Launch of New Product Serranator SL-PRO for CLTI and Pedal Disease

WAYNE, Penn., February 3, 2025 – Cagent Vascular, Inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, today announced the launch of its newest product, Serranator SL-PRO™ PTA Serration Balloon Catheter. Serranator SL-PRO™ is purpose-built for pedal intervention as well as challenging-to-cross tibial disease. Serranator SL-PRO™ utilizes Cagent’s proven Serration Technology on a redesigned platform offering improved deliverability and trackability1, while offering Serranator’s proven 1,000 times increase in point force versus plain balloon.